Boothbay Fund Management, LLC Chemo Centryx, Inc. Put Options Transaction History

Boothbay Fund Management, LLC

$3.6 Billion
Q3 2024

Put Options

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $1.91 Million - $4.2 Million	-103,700 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.18 - $19.83 $64,582 - $97,166	-4,900 Reduced 4.51%	103,700 $1.77 Million
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $1.04 Million - $5.53 Million	108,600 New	108,600 $1.45 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.